BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 28851358)

  • 1. Treatment-seeking patterns for malaria in pharmacies in five sub-Saharan African countries.
    Ladner J; Davis B; Audureau E; Saba J
    Malar J; 2017 Aug; 16(1):353. PubMed ID: 28851358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
    ; Hanson K; Goodman C
    Malar J; 2017 May; 16(1):205. PubMed ID: 28526075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
    ; Tougher S; Hanson K; Goodman C
    Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
    Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
    Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The malaria testing and treatment landscape in mainland Tanzania, 2016.
    ; Michael D; Mkunde SP
    Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsidising artemisinin-based combination therapy in the private retail sector.
    Opiyo N; Yamey G; Garner P
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009926. PubMed ID: 26954551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.
    O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE; Staedke SG; Wiseman VL; Whitty CJM; Hopkins H
    BMC Med; 2020 Jan; 18(1):17. PubMed ID: 31996199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of rapid malaria diagnostic tests upon anti-malarial sales in community pharmacies in Gwagwalada, Nigeria.
    Ikwuobe JO; Faragher BE; Alawode G; Lalloo DG
    Malar J; 2013 Oct; 12():380. PubMed ID: 24172163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Private sector role, readiness and performance for malaria case management in Uganda, 2015.
    ; Kaula H; Buyungo P; Opigo J
    Malar J; 2017 May; 16(1):219. PubMed ID: 28545583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.
    Talisuna AO; Daumerie PG; Balyeku A; Egan T; Piot B; Coghlan R; Lugand M; Bwire G; Rwakimari JB; Ndyomugyenyi R; Kato F; Byangire M; Kagwa P; Sebisubi F; Nahamya D; Bonabana A; Mpanga-Mukasa S; Buyungo P; Lukwago J; Batte A; Nakanwagi G; Tibenderana J; Nayer K; Reddy K; Dokwal N; Rugumambaju S; Kidde S; Banerji J; Jagoe G
    Malar J; 2012 Oct; 11():356. PubMed ID: 23107021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment.
    Maloney K; Ward A; Krenz B; Petty N; Bryson L; Dolkart C; Visser T; Le Menach A; Scott VK; Cohen JM; Mtumbuka E; Mkude S
    Malar J; 2017 Jan; 16(1):6. PubMed ID: 28049481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incentivizing appropriate malaria case management in the private sector: a study protocol for two linked cluster randomized controlled trials to evaluate provider- and client-focused interventions in western Kenya and Lagos, Nigeria.
    Woolsey AM; Simmons RA; Woldeghebriel M; Zhou Y; Ogunsola O; Laing S; Olaleye T; Kipkoech J; Rojas BM; Saran I; Odhiambo M; Malinga J; Ambani G; Kimachas E; Fashanu C; Wiwa O; Menya D; Laktabai J; Visser T; Turner EL; O'Meara WP
    Implement Sci; 2021 Jan; 16(1):14. PubMed ID: 33472650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda.
    Woldeghebriel M; Aso E; Berlin E; Fashanu C; Kirumira SN; Lam F; Mugerwa R; Nakiganda J; Olaleye T; Opigo J; Osinupebi F; Priestley N; Stringham R; Uhomoibhi P; Visser T; Ward A; Wiwa O; Woolsey A
    Malar J; 2024 Feb; 23(1):41. PubMed ID: 38321459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to quality-assured artemisinin-based combination therapy and associated factors among clients of selected private drug outlets in Uganda.
    Ocan M; Nakalembe L; Otike C; Mordecai T; Birungi J; Nsobya S
    Malar J; 2024 Apr; 23(1):128. PubMed ID: 38689257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.
    Prudhomme O'Meara W; Menya D; Laktabai J; Platt A; Saran I; Maffioli E; Kipkoech J; Mohanan M; Turner EL
    PLoS Med; 2018 Jul; 15(7):e1002607. PubMed ID: 30016316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misuse of Artemisinin Combination Therapies by Clients of Medicine Retailers Suspected to Have Malaria Without Prior Parasitological Confirmation in Nigeria.
    Nwokolo E; Ujuju C; Anyanti J; Isiguzo C; Udoye I; BongosIkwue E; Ezire O; Raji M; Oyibo WA
    Int J Health Policy Manag; 2018 Jun; 7(6):542-548. PubMed ID: 29935131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy.
    Ezenduka CC; Ogbonna BO; Ekwunife OI; Okonta MJ; Esimone CO
    Malar J; 2014 Jun; 13():243. PubMed ID: 24961280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
    O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
    Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.
    Davis B; Ladner J; Sams K; Tekinturhan E; de Korte D; Saba J
    Malar J; 2013 Apr; 12():135. PubMed ID: 23607504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in malaria care seeking and dispensing outcomes for adults and children attending drug vendors in Nasarawa, Nigeria.
    Liu J; Isiguzo C; Sieverding M
    Trop Med Int Health; 2015 Aug; 20(8):1081-92. PubMed ID: 25877471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.